Drugging
-
{
- All
- News
- Videos
-
One Injection A Month For Weight Loss? Pfizer's New Obesity Drug Explained
The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this limitation through advanced molecular engineering techniques.
-
Why Promising Lab Drugs Fail: Study Finds How Body Environment Can Flip Drug Effects
Findings published in the journal Nature Structural and Molecular Biology could help explain why drug candidates can look promising in early lab tests but fail later in development.
-
A New Era In Medicine? First Human Dosed in Groundbreaking Aging Reversal Trial
The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of age-related optic nerve damage.
-
Big Bang Theory's Mayim Bialik's GLP-1 Drug Experience Was A "Nightmare": What Happened
Bialik explained that she did not start taking a GLP-1 drug simply to lose weight. Instead, she hoped it might help with health issues that had affected her for years.
-
Delhi Cop Demanded Rs 3 Crore Bribe To Influence CBI's Fake Drugs Probe
During a meeting in Delhi, a senior government official allegedly assured the accused he could secure them the outcome they wanted in the CBI case.
-
Highly Effective Prevention Drug Arrives In South Africa, Which Has World's Highest HIV Burden
South Africa launches lenacapavir, a twice-yearly injectable HIV prevention drug, aiming to reduce new infections in the country with the highest HIV burden globally.
-
New Long Acting Oral HIV Regimen Meets Primary Endpoints In Phase 3 Trials
The combination of islatravir and lenacapavir targets multiple stages of HIV-1 replication, potentially offering people with HIV who are virologically suppressed a novel, long-acting oral single-tablet regimen.
-
Weight Loss Drugs Reduce The Risk Of Breast Cancer By 30%, Finds New Study
Researchers examined health records to compare women who used GLP-1 medications with those who did not. The results showed that women taking these drugs were about 30% less likely to develop breast cancer than women who were not using them.
-
In J&K, Music Strikes A Chord Against Rising Drug Threat
The musical evening was organised by FICCI FLO Jammu & Kashmir under its 'Jammu Yuva' programme, an initiative aimed at raising awareness about the drug menace and how it is jeopardising the future of the younger generation.
-
Harvard-Trained Gastroenterologist Reveals What Most People Miss About GLP-1 Drugs
Strap: A Harvard- and Stanford-trained gastroenterologist shares some key facts on GLP-1 drugs that most people often ignore.
-
The Big Bang Theory Star Mayim Bialik On GLP-1 "Nightmare": 'Diarrhoea, Sulphur Burps, Sneezing Attacks'
Mayim Bialik took a GLP-1 shot, but her "dramatic" reaction - explosive diarrhoea, sulphur burps, sneezing attacks, cramping, bloating, and body ache - made her give away the remaining shots worth hundreds of dollars
-
Exclusive: Biggest Pancreatic Cancer Breakthrough In 50 Years, Says Indian Doctor, Co-Author Of Global Clinical Trial
Daraxonrasib belongs to a new class of medicines known as RAS(ON) inhibitors. The drug targets the active form of RAS proteins, which help drive tumour growth and survival.
-
Ovarian Cancer Breakthrough: New Targeted Drug Extends Survival, Improves Quality Of Life
A breakthrough targeted therapy, mirvetuximab soravtansine, is offering new hope to women with hard-to-treat ovarian cancer. Studies show it extends survival, slows disease progression, shrinks tumours and improves quality of life compared to chemotherapy.
-
New Diabetes Drug Targets Metabolism, Avoids Ozempic Side Effects
Early studies suggest that it can lower blood sugar levels and increase fat burning while preserving muscle mass and normal appetite. This makes it a good option for people who struggle with the nausea, appetite loss, and muscle reduction.
-
Smart Cancer Drug Can Shrink Tumours By 30% In Early Trial
In an early-stage (Phase 1) trial of 83 patients, the drug shrank tumours in 26 people. For 15 of those patients, their tumours shrank by at least 30%.
-
One Injection A Month For Weight Loss? Pfizer's New Obesity Drug Explained
The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this limitation through advanced molecular engineering techniques.
-
Why Promising Lab Drugs Fail: Study Finds How Body Environment Can Flip Drug Effects
Findings published in the journal Nature Structural and Molecular Biology could help explain why drug candidates can look promising in early lab tests but fail later in development.
-
A New Era In Medicine? First Human Dosed in Groundbreaking Aging Reversal Trial
The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of age-related optic nerve damage.
-
Big Bang Theory's Mayim Bialik's GLP-1 Drug Experience Was A "Nightmare": What Happened
Bialik explained that she did not start taking a GLP-1 drug simply to lose weight. Instead, she hoped it might help with health issues that had affected her for years.
-
Delhi Cop Demanded Rs 3 Crore Bribe To Influence CBI's Fake Drugs Probe
During a meeting in Delhi, a senior government official allegedly assured the accused he could secure them the outcome they wanted in the CBI case.
-
Highly Effective Prevention Drug Arrives In South Africa, Which Has World's Highest HIV Burden
South Africa launches lenacapavir, a twice-yearly injectable HIV prevention drug, aiming to reduce new infections in the country with the highest HIV burden globally.
-
New Long Acting Oral HIV Regimen Meets Primary Endpoints In Phase 3 Trials
The combination of islatravir and lenacapavir targets multiple stages of HIV-1 replication, potentially offering people with HIV who are virologically suppressed a novel, long-acting oral single-tablet regimen.
-
Weight Loss Drugs Reduce The Risk Of Breast Cancer By 30%, Finds New Study
Researchers examined health records to compare women who used GLP-1 medications with those who did not. The results showed that women taking these drugs were about 30% less likely to develop breast cancer than women who were not using them.
-
In J&K, Music Strikes A Chord Against Rising Drug Threat
The musical evening was organised by FICCI FLO Jammu & Kashmir under its 'Jammu Yuva' programme, an initiative aimed at raising awareness about the drug menace and how it is jeopardising the future of the younger generation.
-
Harvard-Trained Gastroenterologist Reveals What Most People Miss About GLP-1 Drugs
Strap: A Harvard- and Stanford-trained gastroenterologist shares some key facts on GLP-1 drugs that most people often ignore.
-
The Big Bang Theory Star Mayim Bialik On GLP-1 "Nightmare": 'Diarrhoea, Sulphur Burps, Sneezing Attacks'
Mayim Bialik took a GLP-1 shot, but her "dramatic" reaction - explosive diarrhoea, sulphur burps, sneezing attacks, cramping, bloating, and body ache - made her give away the remaining shots worth hundreds of dollars
-
Exclusive: Biggest Pancreatic Cancer Breakthrough In 50 Years, Says Indian Doctor, Co-Author Of Global Clinical Trial
Daraxonrasib belongs to a new class of medicines known as RAS(ON) inhibitors. The drug targets the active form of RAS proteins, which help drive tumour growth and survival.
-
Ovarian Cancer Breakthrough: New Targeted Drug Extends Survival, Improves Quality Of Life
A breakthrough targeted therapy, mirvetuximab soravtansine, is offering new hope to women with hard-to-treat ovarian cancer. Studies show it extends survival, slows disease progression, shrinks tumours and improves quality of life compared to chemotherapy.
-
New Diabetes Drug Targets Metabolism, Avoids Ozempic Side Effects
Early studies suggest that it can lower blood sugar levels and increase fat burning while preserving muscle mass and normal appetite. This makes it a good option for people who struggle with the nausea, appetite loss, and muscle reduction.
-
Smart Cancer Drug Can Shrink Tumours By 30% In Early Trial
In an early-stage (Phase 1) trial of 83 patients, the drug shrank tumours in 26 people. For 15 of those patients, their tumours shrank by at least 30%.
